REJUVERON LIFE SCIENCES
Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.
REJUVERON LIFE SCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Status:
Active
Total Funding:
25.01 M USD
Technology used in webpage:
Content Delivery Network Metanet
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Bob Silverman Chief Business Officer @ Rejuveron Life Sciences
Chief Business Officer
2021-08-01
Founder
Investors List
What If Ventures
What If Ventures investment in Series B - Rejuveron Life Sciences
re.Mind Capital
re.Mind Capital investment in Series B - Rejuveron Life Sciences
Apeiron Investment Group
Apeiron Investment Group investment in Series B - Rejuveron Life Sciences
Gaingels
Gaingels investment in Series B - Rejuveron Life Sciences
Ava Investors
Ava Investors investment in Series B - Rejuveron Life Sciences
10X Capital
10X Capital investment in Series A - Rejuveron Life Sciences
Korify Capital AG
Korify Capital AG investment in Series A - Rejuveron Life Sciences
infinitas capital group
infinitas capital group investment in Series A - Rejuveron Life Sciences
Gaingels
Gaingels investment in Series A - Rejuveron Life Sciences
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-12-13 | Endogena | Rejuveron Life Sciences investment in Series A - Endogena | 21 M USD |
2021-10-12 | Rejuvenate Biomed | Rejuveron Life Sciences investment in Series B - Rejuvenate Biomed | 15.7 M EUR |
2021-01-28 | Endogena | Rejuveron Life Sciences investment in Series A - Endogena | 8 M USD |
Key Employee Changes
Date | New article |
---|---|
2021-11-19 | Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York |
More informations about "Rejuveron Life Sciences"
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and …
Sep 19, 2024 · Centenara Labs AG (“Centenara” or the “Company”) (formerly Rejuveron Life Sciences AG), a Zurich-based biotechnology company focused on pioneering therapies to …See details»
Rejuveron Life Sciences - Crunchbase
Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to …See details»
Centenara Labs AG
Our innovative organization is focused on transforming the most promising discoveries in aging research into therapies that extend people’s good health years and improve overall lifespan.See details»
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and …
Sep 19, 2024 · SCHLIEREN, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) — Centenara Labs AG (“Centenara” or the “Company”) (formerly Rejuveron Life Sciences AG), a Zurich …See details»
Rejuveron Life Sciences rejuvenates as Centenara Labs
Sep 23, 2024 · The biotech, as Rejuveron Life Sciences AG, raised $75 million in dual tranche series B and convertible loan financing one year ago this month and is focused on a small …See details»
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and …
Sep 19, 2024 · By focusing on advancing novel therapeutic approach through targeting the root cause of age-related diseases, Centenara aims to extend health span — ensuring that …See details»
Rejuveron Increases to Near-majority Stake in …
Dec 13, 2021 · Rejuveron has funded a further $20m in the $29 million series A financing round to enable Endogena to progress treatments targeting degenerative diseases of the eye.See details»
Extending healthspans by targeting the hallmarks of …
Rejuveron’s breakthrough therapeutics are set to transform the treatment of age-related diseases by targeting the root causes of aging. Diseases associated with aging have a profound impact on...See details»
Creatingtherapiesforimproved aging and longer lives - Nature
Rejuveron, based in Zürich, Switzerland, and founded in 2019, is an integrated biotechnology company that aims to deliver innovative therapies …See details»
Creating therapies for improved aging and longer lives
Rejuveron, based in Zürich, Switzerland, and founded in 2019, is an integrated biotechnology company that aims to deliver innovative therapies and technologies to promote healthy aging and help...See details»
Centenara Labs AG – Swiss Biotech
Rejuveron is an integrated biotechnology platform company that develops and improves therapies and technologies to promote healthy aging and prolong lifespan. We provide start-up coaching and funding to entrepreneurial …See details»
Centenara Labs Company Profile 2024: Valuation, Funding
The company's drugs focus on finding cures for age-related diseases and advancing science and technology and offer services such as drug discovery expertise, financial support, legal and …See details»
Rejuveron Transitions to Become a Clinical Stage Company as …
Mar 28, 2022 · Rejuveron Life Sciences AG (‘Rejuveron’), a Zürich-based biotechnology company developing therapies to promote healthy aging, today announced that Rejuvenate Biomed NV …See details»
Rejuveron Life Sciences - Funding, Financials, Valuation & Investors
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.See details»
Rejuveron Life Sciences AG today announced that it will ultimately ...
Oct 11, 2021 · Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy …See details»
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and
Sep 19, 2024 · SCHLIEREN, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Centenara Labs AG (“Centenara” or the “Company”) (formerly Rejuveron Life Sciences AG), a Zurich …See details»
Endogena therapeutics clinical trial | Lifespan.io
Jul 12, 2022 · Rejuveron has a near-majority holding in Endogena, an endogenous regenerative therapeutics company, announcing in late 2021 that it had invested a further $20m in …See details»
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG
Sep 19, 2024 · SCHLIEREN, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Centenara Labs AG (“ Centenara ” or the “ Company ”) (formerly Rejuveron Life Sciences AG), a Zurich …See details»
Rejuveron Appoints Roche Veteran Bob Silverman as Chief …
ZURICH and NEW YORK, Nov. 19, 2021 /PRNewswire/ -- Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, has announced the …See details»
Defining a longevity biotechnology company - Nature
Jun 26, 2023 · Longevity biotechnology companies (LBCs) are organizations developing and testing therapeutics to test the geroscience hypothesis — the idea that, because aging …See details»